Cite
HARVARD Citation
Paszkiewicz‐Kozik, E. et al. (2022). Ofatumumab with iphosphamide, etoposide and cytarabine for patients with transplantation‐ineligible relapsed and refractory diffuse large B‐cell lymphoma. British journal of haematology. pp. 73-81. [Online].